SCHEMBL352052

SCHEMBL352052

C1CCN(Cc2nnn[nH]2)CC1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.40
HRH3 Q9Y5N1 2/20 0.39
ALDH1A1 P00352 6/20 0.38
MAPT P10636 2/20 0.38
TP53 P04637 1/20 0.38
KDM4E B2RXH2 2/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ALOX15 P16050 2/20 0.37
KMT2A Q03164 3/20 0.36
HRH4 Q9H3N8 1/20 0.35
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
RAB9A P51151 1/20 0.32
ATM Q13315 1/20 0.32
PTPN1 P18031 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17002547 0.94 ALOX15 (0.38) HTTHRH3ALDH1A1MAPTTP53
SCHEMBL458869 0.82 SIGMAR1 (0.40) HRH3ALDH1A1ALOX15KMT2AMEN1
SCHEMBL14569839 0.82 ALDH1A1 (0.42) ALDH1A1MAPTKDM4EALOX15HRH4
SCHEMBL6475272 0.82 ALOX15 (0.36) ALOX15
SCHEMBL4982004 0.81 HPGD (0.43) HTTHRH3ALDH1A1MAPTKDM4E
SCHEMBL19853515 0.78 ACHE (0.42) HRH3ALDH1A1KDM4EHSD17B10ALOX15
SCHEMBL14558083 0.78 ALDH1A1 (0.36) HRH3ALDH1A1KDM4EALOX15
SCHEMBL17002581 0.74 ALDH1A1 (0.31) ALDH1A1ALOX15
SCHEMBL19307814 0.69 DRD4 (0.47) HTTALDH1A1MAPTKDM4E
SCHEMBL7053027 0.68 HRH3 (0.30) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150291874-A1 METHODS FOR MAKING AND USING NOVEL FOAMER COMPOSITIONS WEATHERFORD TECHNOLOGY HOLDINGS, LLC 2015-10-15 US claimed
US-9018145-B2 Foamer composition and methods for making and using same Lubrizol Oilfield Solutions, Inc. (US) 2015-04-28 US claimed
US-8714283-B2 Foamer/sulfur scavenger composition and methods for making and using same CLEARWATER INTERNATIONAL, LLC (US) 2014-05-06 US claimed
US-20120088697-A1 FOAMER/SULFUR SCAVENGER COMPOSITION AND METHODS FOR MAKING AND USING SAME WEATHERFORD/LAMB, INC. 2012-04-12 US claimed
US-20050250666-A1 Foamer/sulfur scavenger composition and methods for making and using same WEATHERFORD/LAMB, INC. 2005-11-10 US claimed
US-20050137114-A1 environmentally friendly, biodegradable, nondepositing and high temperatures resistant aqueous foaming agents comprising a mixture of anionic, cationic and zwitterionic surfactants, used as drilling fluids WEATHERFORD/LAMB, INC. 2005-06-23 US claimed
US-12605737-B2 Methods of temporarily enhancing the luster and brilliance of jewelry and gem stones ASHLEY PAUL (US) 2026-04-21 US disclosed
EP-4518842-A1 NOVEL LIPID-BASED SMALL MOLECULE INTEGRIN RECEPTOR-LIGAND AGONIST ADJUVANTS CARRIER COMPOSITIONS, INTEGRIN AGONIST ADJUVANT PHARMACEUTICAL COMPOSITIONS THEREFROM, AND METHODS FOR MAKING AND USING SAME 7 Hills Pharma Inc. (US) 2025-03-12 EP disclosed
CN-119546288-A Novel lipid-based small molecule integrin receptor-ligand agonist adjuvant carrier compositions, integrin agonist adjuvant pharmaceutical compositions thereof, and methods of making and using the same 7山药物公司 2025-02-28 CN disclosed
US-12023707-B2 Methods of temporarily enhancing the luster and brilliance of jewelry and gem stones ASHLEY PAUL (US) 2024-07-02 US disclosed
US-20240191129-A1 WATER-BASED FRICTION-REDUCING SLURRY COMPOSITIONS, FORMATION TREATING FLUIDS THEREFROM, AND METHOD FOR MAKING AND USING SAME PfP Industries LLC (US) 2024-06-13 US disclosed
US-11932811-B2 Composition and methods for enhancing the production of hydrocarbons NEXTIER COMPLETION SOLUTIONS INC. (US) 2024-03-19 US disclosed
US-20230372253-A1 NOVEL LIPID-BASED SMALL MOLECULE INTEGRIN RECEPTOR-LIGAND AGONIST ADJUVANTS CARRIER COMPOSITIONS, INTEGRIN AGONIST ADJUVANT PHARMACEUTICAL COMPOSITIONS THEREFROM, AND METHODS FOR MAKING AND USING SAME 7 Hills Pharma LLC (US) 2023-11-23 US disclosed
US-20120015146-A1 TYPES OF ELECTRODEPOSITED POLYMER COATINGS WITH REVERSIBLE WETTABILITY AND ELECTRO-OPTICAL PROPERTIES THE UNIVERSITY OF HOUSTON SYSTEM (US) 2012-01-19 US disclosed
US-7971659-B2 Foamer/sulfur scavenger composition and methods for making and using same CLEARWATER INTERNATIONAL, LLC (US) 2011-07-05 US disclosed
EP-2172532-A2 Stable foamed cement slurry compositions and methods for making and using same Clearwater International, L.L.C (US) 2010-04-07 EP disclosed
US-20100077938-A1 STABLE FOAMED CEMENT SLURRY COMPOSITIONS AND METHODS FOR MAKING AND USING SAME CLEARWATER INTERNATIONAL, LLC, A DELAWARE CORPORATION 2010-04-01 US disclosed
US-20050250666-A1 Foamer/sulfur scavenger composition and methods for making and using same WEATHERFORD/LAMB, INC. 2005-11-10 US disclosed
US-20050137114-A1 environmentally friendly, biodegradable, nondepositing and high temperatures resistant aqueous foaming agents comprising a mixture of anionic, cationic and zwitterionic surfactants, used as drilling fluids WEATHERFORD/LAMB, INC. 2005-06-23 US disclosed
CN-1126471-A Tetrazole derivatives SUMITOMO METAL IND (JP) 1996-07-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12605737-B2 Methods of temporarily enhancing the luster and brilliance of jewelry and gem stones LAGE3, ATXN10, BUB3 HTT 3428/4885HRH3 1188/4885ALDH1A1 3950/4885
US-20230372253-A1 NOVEL LIPID-BASED SMALL MOLECULE INTEGRIN RECEPTOR-LIGAND AGONIST ADJUVANTS CARRIER COMPOSITIONS, INTEGRIN AGONIST ADJUVANT PHARMACEUTICAL COMPOSITIONS THEREFROM, AND METHODS FOR MAKING AND USING SAME ITGAM, ITGA2, ADGRF1 HTT 4583/4885HRH3 991/4885ALDH1A1 2762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.